Literature DB >> 22378257

Trial watch: integrin antagonist shows promise in MS.

Sarah Crunkhorn.   

Abstract

Mesh：

Substances：

Year:  2012        PMID： 22378257     DOI： 10.1038/nrd3676

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  1 in total

1.  Success of immunomodulators in MS shifts discovery focus to neuroprotection.

Authors:  Asher Mullard
Journal:  Nat Rev Drug Discov       Date:  2011-12-01       Impact factor: 84.694
  1 in total
  2 in total

1.  Market watch: Where is personalized medicine in industry heading?

Authors:  Christopher-Paul Milne; Joshua P Cohen; Ranjana Chakravarthy
Journal:  Nat Rev Drug Discov       Date:  2015-10-16       Impact factor: 84.694

Review 2.  Adhesion molecules in CNS disorders: biomarker and therapeutic targets.

Authors:  Qingyi Ma; Sheng Chen; Damon Klebe; John H Zhang; Jiping Tang
Journal:  CNS Neurol Disord Drug Targets       Date:  2013-05-01       Impact factor: 4.388
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.